Cited 0 times in
Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | An, TJ | - |
dc.contributor.author | Lee, YJ | - |
dc.contributor.author | Park, JE | - |
dc.contributor.author | Lee, EG | - |
dc.contributor.author | Kim, Y | - |
dc.contributor.author | Kang, SY | - |
dc.contributor.author | Joo, H | - |
dc.contributor.author | Choi, JY | - |
dc.date.accessioned | 2023-02-21T04:34:04Z | - |
dc.date.available | 2023-02-21T04:34:04Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/24781 | - |
dc.language.iso | en | - |
dc.title | Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease | - |
dc.type | Article | - |
dc.identifier.pmid | 35950320 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537655 | - |
dc.contributor.affiliatedAuthor | Park, JE | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.4046/trd.2022.0072 | - |
dc.citation.title | Tuberculosis and respiratory diseases | - |
dc.citation.volume | 85 | - |
dc.citation.number | 4 | - |
dc.citation.date | 2022 | - |
dc.citation.startPage | 358 | - |
dc.citation.endPage | 360 | - |
dc.identifier.bibliographicCitation | Tuberculosis and respiratory diseases, 85(4). : 358-360, 2022 | - |
dc.identifier.eissn | 2005-6184 | - |
dc.relation.journalid | J017383536 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.